ARYA Sciences Acquisition Corp IV
ARYA Sciences Acquisition Corp IV（ARYD）股东结构
基于 13F 申报与流通股数据，展示机构、内部人与公众持股结构；下方为前十大机构、机构动向与内部人交易。
SEC 13F · FMP · ARYD · 截至 2024年6月30日
股东结构概览
19
机构持有人数
▼ 2 vs Q1
$26.86M
机构持仓总市值
▼ $5.31M vs Q1
7.54M
总流通股
freeFloat 43.79%
2.34M
13F 申报持股数
▼ 518,402 vs Q1
机构持仓% = 13F 持股数 ÷ 总流通股。内部人% = 100 − 自由流通率。散户% = 自由流通率 − 机构%。数据来源：FMP /symbol-positions-summary + /shares-float + SEC EDGAR。
前10大机构持仓
ARYD 最大股东 · 机构持仓
Q2 2024 · SEC 13F
显示前 10 家
| 机构 | 持股数 | 占比 | 权重 | 市值 | 申报日 | 变动 |
|---|---|---|---|---|---|---|
BERKLEY W R CORP biological products, (no diagnostic substances) | 319.5K | 4.10% | 4.10% | $3.66B | Aug 14, 2024 | — held |
GLAZER CAPITAL, LLC biological products, (no diagnostic substances) | 235.1K | 3.02% | 3.02% | $2.70B | Aug 14, 2024 | ▼ 97.5K |
FIR TREE CAPITAL MANAGEMENT LP biological products, (no diagnostic substances) | 230.6K | 2.96% | 2.96% | $2.64B | Aug 14, 2024 | ▲ 205.7K |
MIZUHO SECURITIES USA LLC biological products, (no diagnostic substances) | 208.8K | 2.68% | 2.68% | $2.37B | Jul 31, 2024 | ▼ 33.1K |
FARALLON CAPITAL MANAGEMENT LLC biological products, (no diagnostic substances) | 200.0K | 2.57% | 2.57% | $2.29B | Aug 14, 2024 | — held |
COWEN AND COMPANY, LLC biological products, (no diagnostic substances) | 174.3K | 2.24% | 2.24% | $2.00B | Aug 7, 2024 | ▼ 89.1K |
TENOR CAPITAL MANAGEMENT CO., L.P. biological products, (no diagnostic substances) | 150.0K | 1.93% | 1.93% | $1.72B | Aug 14, 2024 | — held |
HSBC HOLDINGS PLC biological products, (no diagnostic substances) | 149.9K | 1.93% | 1.93% | $1.72B | Aug 12, 2024 | — held |
AFFINITY ASSET ADVISORS, LLC biological products, (no diagnostic substances) | 133.5K | 1.72% | 1.72% | $1.53B | Aug 14, 2024 | — held |
RTW INVESTMENTS, LP biological products, (no diagnostic substances) | 128.0K | 1.64% | 1.64% | $1.47B | Aug 14, 2024 | — held |
数据来源：SEC 13F 申报文件。变动标识：isNew / isSoldOut / changeInSharesNumber。
机构仓位变动
Q2 2024 对比上季度
Q2 2024
4
增持
+218.3K 股1
新建仓
首次建仓3
减持
−219.7K 股3
清仓
完全退出净股数变化（前50家）
1.4K
+218.3K / −219.7K
净新增持仓人
-1
新建 1 个 / 退出 3 个
基于前50家最大机构持仓统计，全市场实际数量可能不同。
内幕交易买卖情绪
ARYD 内幕交易记录
数据来源：SEC Form 4
0
买入笔数
12
卖出笔数
0.00
买卖比
$13M
卖出总金额
最近内幕交易记录
最近10条 · 仅普通股
| 姓名 · 职位 | 日期 | 类型 | 股数 | 价格 | 金额 | 交易后持股 | 申报 |
|---|---|---|---|---|---|---|---|
Stone Adam Leo Chief Executive Officer | Jul 31, 2024 | D-Return | 1,000,000 | — | — | 2.65M | Form 4 ↗ |
Stone Adam Leo Chief Executive Officer | Jul 31, 2024 | D-Return | 2,647,500 | — | — | 0 | Form 4 ↗ |
Stone Adam Leo Chief Executive Officer | Jul 31, 2024 | D-Return | 499,000 | $24.00 | $11.98M | 0 | Form 4 ↗ |
HENDERSON MICHAEL THOMAS director | Jul 31, 2024 | D-Return | 30,000 | — | — | 0 | Form 4 ↗ |
Trigg Leslie director | Jul 31, 2024 | D-Return | 30,000 | — | — | 0 | Form 4 ↗ |
Wider Todd director | Jul 31, 2024 | D-Return | 30,000 | — | — | 0 | Form 4 ↗ |
ARYA Sciences Holdings IV 10 percent owner | Jul 31, 2024 | D-Return | 1,000,000 | — | — | 2.65M | Form 4 ↗ |
ARYA Sciences Holdings IV 10 percent owner | Jul 31, 2024 | D-Return | 2,647,500 | — | — | 0 | Form 4 ↗ |
ARYA Sciences Holdings IV 10 percent owner | Jul 31, 2024 | D-Return | 499,000 | $24.00 | $11.98M | 0 | Form 4 ↗ |
ALTMAN MICHAEL SETH Chief Financial Officer | Jul 31, 2024 | D-Return | 1,000,000 | — | — | 2.65M | Form 4 ↗ |
数据来源：SEC Form 4。买卖方向：acquisitionOrDisposition A=买入，D=卖出。已排除 RSU 归属（M-Exempt）。
关于机构与内部人持股结构
ARYA Sciences Acquisition Corp IV（ARYD）主要由机构投资者持有，机构持股比例约为 31.1%。公司内部人员持股约 56.21%，散户及公众持股约占剩余的 12.68%。
ARYA Sciences Acquisition Corp IV 最大机构股东为 BERKLEY W R CORP，截至 June 30, 2024 持有约 319,460 股，占总流通股的 4.10%。
目前共有 19 家机构持有 ARYD 股票，合计持仓市值约 $26,858,128，数据来源为最新 SEC 13F 申报。
常见问题
ARYD ownershipARYA Sciences Acquisition Corp IV（ARYD）主要由机构投资者持有，机构持股约 31.1%。最大股东为 BERKLEY W R CORP，持股比例 4.10%。内部人员持股约 56.21%。数据来源 SEC Form 13F，截至 June 30, 2024。